Insmed Inc (INSM) Company Report Oct. 27, 2022, 07:05 UTC 70 0 comments New SEC Filing for Insmed Inc. (NASDAQ:INSM) Comment Full text
Neurocrine Biosciences Inc (NBIX) Company Report Oct. 27, 2022, 06:44 UTC 79 0 comments Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Adults with Schizophrenia Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Oct. 27, 2022, 06:44 UTC 77 0 comments Rigel Announces Conference Call and Webcast to Report Third Quarter 2022 Financial Results and Business Update Comment Full text
Alnylam Pharmaceuticals Inc (ALNY) Company Report Oct. 27, 2022, 06:43 UTC 76 0 comments New Form 10-Q for Alnylam Pharmaceuticals, Inc. Comment Full text
Mustang Bio Inc (MBIO) Company Report Oct. 27, 2022, 06:21 UTC 74 0 comments Mustang Bio Announces Phase 1/2 Clinical Trial Data of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy, to be Presented at 11th International Workshop for Waldenstroms Macroglobulinemia Comment Full text
Humanigen Inc. (HGEN) Company Report Oct. 26, 2022, 13:59 UTC 77 0 comments Humanigen Inc. Website - Validate Account Comment Full text
Supernus Pharmaceuticals Inc (SUPN) Company Report Oct. 25, 2022, 14:40 UTC 79 0 comments New Form 8-K for Supernus Pharmaceuticals Comment Full text
Enochian Biosciences Inc. (ENOB) Company Report Oct. 25, 2022, 11:36 UTC 74 0 comments Enochian Biosciences Inc. Website - Validate Account Comment Full text
Diffusion Pharmaceuticals Inc. (DFFN) Company Report Oct. 25, 2022, 06:58 UTC 72 0 comments Diffusion Pharmaceuticals Inc. - Validate Account Comment Full text
Applied Genetic Technologies Corporation (AGTC) Company Report Oct. 24, 2022, 14:32 UTC 77 0 comments New Form 10-K/A for Applied Genetic Technologies Corporation Comment Full text